Literature DB >> 28865162

Three new cases of bullous pemphigoid during anti-PD-1 antibody therapy.

S Le Naour1, L Peuvrel1,2,3,4, M Saint-Jean1,2,3,4, B Dreno1,2,3,4, G Quereux1,2,3,4.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28865162     DOI： 10.1111/jdv.14579

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  7 in total

Review 1.  Cutaneous toxicities of new treatments for melanoma.

Authors:  A Boada; C Carrera; S Segura; H Collgros; P Pasquali; D Bodet; S Puig; J Malvehy
Journal:  Clin Transl Oncol       Date:  2018-05-24       Impact factor: 3.405

Review 2.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

Review 3.  Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Authors:  Chun-Bing Chen; Ming-Ying Wu; Chau Yee Ng; Chun-Wei Lu; Jennifer Wu; Pei-Han Kao; Chan-Keng Yang; Meng-Ting Peng; Chen-Yang Huang; Wen-Cheng Chang; Rosaline Chung-Yee Hui; Chih-Hsun Yang; Shun-Fa Yang; Wen-Hung Chung; Shih-Chi Su
Journal:  Cancer Manag Res       Date:  2018-05-17       Impact factor: 3.989

4.  Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.

Authors:  Coralie Zumelzu; Marina Alexandre; Christelle Le Roux; Patricia Weber; Alexis Guyot; Annie Levy; Françoise Aucouturier; Sabine Mignot-Grootenboer; Frédéric Caux; Eve Maubec; Catherine Prost-Squarcioni
Journal:  Front Med (Lausanne)       Date:  2018-09-27

Review 5.  Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab.

Authors:  Rohan R Shah; Chinmoy Bhate; Amanda Hernandez; Chin Hung Ho
Journal:  Dermatol Ther       Date:  2022-03-15       Impact factor: 3.858

6.  A Case of Systemic Severe Bullous Pemphigoid Caused by Long-Term Sintilimab Treatment for Renal Cell Carcinoma.

Authors:  Jia He; Xi Duan; Ting Liu; Hao Yang; Jingjing Jiang; Yunzhu Mu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-10

7.  Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab.

Authors:  Kayo Tanita; Taku Fujimura; Yumi Kambayashi; Akira Tsukada; Yota Sato; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Oncol       Date:  2018-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.